celecoxib has been researched along with D-fructopyranose in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JY; Cheng, WT; Hsieh, PS; Kuo, CH; Liu, TT; Shyu, JF; Tsai, HC | 1 |
| Benatar, M; Kurent, J; Moore, DH | 1 |
| Allena, M; Ferrante, E; Lisotto, C; Nappi, G; Rossi, P; Tassorelli, C | 1 |
| Cudkowicz, ME; Drory, VE; Hirsch, J; Nefussy, B | 1 |
| Supuran, CT | 1 |
| Chen, L; Chen, X; Hu, J; Li, S; Lu, Y; Meng, Y; Qiu, Z; Song, Y; Zhang, C; Zheng, G | 1 |
3 review(s) available for celecoxib and D-fructopyranose
| Article | Year |
|---|---|
Treatment for familial amyotrophic lateral sclerosis/motor neuron disease.
Topics: Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Creatine; Fructose; Humans; Motor Neuron Disease; Neuroprotective Agents; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Topiramate | 2009 |
Focus on therapy: hemicrania continua and new daily persistent headache.
Topics: Amines; Analgesics; Celecoxib; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Headache; Headache Disorders; Humans; Indomethacin; Pyrazoles; Sulfonamides; Topiramate; Treatment Outcome | 2010 |
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Celecoxib; Clinical Trials as Topic; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Isoxazoles; Methazolamide; Phenobarbital; Sulfanilamide; Sulfanilamides; Sulfonamides; Sulfonic Acids; Thiazines; Thiophenes; Topiramate; Zonisamide | 2016 |
3 other study(ies) available for celecoxib and D-fructopyranose
| Article | Year |
|---|---|
Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats.
Topics: Animals; Blood Glucose; Blood Pressure; Celecoxib; Cyclooxygenase Inhibitors; Fructose; Immunoblotting; Insulin; Insulin Resistance; Male; Piroxicam; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2008 |
Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Celecoxib; Disease Progression; Dyslipidemias; Female; Fructose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrazoles; Randomized Controlled Trials as Topic; Severity of Illness Index; Sex Characteristics; Sulfonamides; Topiramate | 2011 |
Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt-dependent lipogenic pathway.
Topics: Animals; Celecoxib; Fructose; Humans; Insulins; Lipogenesis; Liver; Mice; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-akt | 2022 |